Hepatoprotective effect of antidysbiotic drugs in experimental metabolic syndrome
Keywordsliver, metabolic syndrome, dysbiosis, immunodeficiency, antidisbiotic drugs
AbstractModeling of experimental metabolic syndrome in Wistar male rats was accompanied by a sharp increase in neutrophils/lymphocytes ratio and decrease in the numbers of monocytes in the blood, as well as almost 5-fold increase in the urease activity, a 3-fold decrease in the activity of lysozyme, and significant increase in the levels of inflammatory markers (MDA and elastase) in the liver. A 13-fold increase was observed in the level of dysbiosis in the liver and a significant increase in the alkaline phosphatase activity. Using antidysbiotic drugs (Quertulin, Quertgial and lysozyme) normalized the state of liver.
How to Cite
VASIUK, V. L., LEVITSKY, A. P. & LEVCHENKO, E. M. Hepatoprotective effect of antidysbiotic drugs in experimental metabolic syndrome. Journal of Education, Health and Sport [online]. 30 October 2017, T. 7, nr 10, s. 290–297. [accessed 31.3.2023].
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Number of views and downloads: 58
Number of citations: 0